358 related articles for article (PubMed ID: 16472263)
1. How have we been managing chronic obstructive pulmonary disease in Australia?
Matheson MC; Abeysena C; Raven JM; Skoric B; Johns DP; Abramson MJ; Walters EH
Intern Med J; 2006 Feb; 36(2):92-9. PubMed ID: 16472263
[TBL] [Abstract][Full Text] [Related]
2. External validity of randomized controlled trials in COPD.
Travers J; Marsh S; Caldwell B; Williams M; Aldington S; Weatherall M; Shirtcliffe P; Beasley R
Respir Med; 2007 Jun; 101(6):1313-20. PubMed ID: 17113277
[TBL] [Abstract][Full Text] [Related]
3. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.
Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ
J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970
[TBL] [Abstract][Full Text] [Related]
4. The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea.
Kim SJ; Suk MH; Choi HM; Kimm KC; Jung KH; Lee SY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
Int J Tuberc Lung Dis; 2006 Dec; 10(12):1393-8. PubMed ID: 17167958
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits.
Lindberg A; Jonsson AC; Rönmark E; Lundgren R; Larsson LG; Lundbäck B
Respiration; 2005; 72(5):471-9. PubMed ID: 16210885
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.
Zhong N; Wang C; Yao W; Chen P; Kang J; Huang S; Chen B; Wang C; Ni D; Zhou Y; Liu S; Wang X; Wang D; Lu J; Zheng J; Ran P
Am J Respir Crit Care Med; 2007 Oct; 176(8):753-60. PubMed ID: 17575095
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.
Lindberg A; Bjerg A; Rönmark E; Larsson LG; Lundbäck B
Respir Med; 2006 Feb; 100(2):264-72. PubMed ID: 15975774
[TBL] [Abstract][Full Text] [Related]
8. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
[TBL] [Abstract][Full Text] [Related]
9. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
10. [The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study].
Geldmacher H; Biller H; Herbst A; Urbanski K; Allison M; Buist AS; Hohlfeld JM; Welte T
Dtsch Med Wochenschr; 2008 Dec; 133(50):2609-14. PubMed ID: 19052996
[TBL] [Abstract][Full Text] [Related]
11. COPD 'diagnosis' based on spirometric reference equations.
Olofson J; Bake B; Tengelin MN; Houltz B
Clin Respir J; 2008 Oct; 2(4):214-9. PubMed ID: 20298337
[TBL] [Abstract][Full Text] [Related]
12. Tiotropium in COPD patients not previously receiving maintenance respiratory medications.
Adams SG; Anzueto A; Briggs DD; Menjoge SS; Kesten S
Respir Med; 2006 Sep; 100(9):1495-503. PubMed ID: 16698259
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease.
Ágh T; Inotai A; Mészáros Á
Respiration; 2011; 82(4):328-34. PubMed ID: 21454953
[TBL] [Abstract][Full Text] [Related]
14. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.
Bridevaux PO; Gerbase MW; Probst-Hensch NM; Schindler C; Gaspoz JM; Rochat T
Thorax; 2008 Sep; 63(9):768-74. PubMed ID: 18505800
[TBL] [Abstract][Full Text] [Related]
15. The 2007 GOLD Guidelines: a comprehensive care framework.
Gold PM
Respir Care; 2009 Aug; 54(8):1040-9. PubMed ID: 19650945
[TBL] [Abstract][Full Text] [Related]
16. Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study.
Maleki-Yazdi MR; Lewczuk CK; Haddon JM; Choudry N; Ryan N
COPD; 2007 Dec; 4(4):313-20. PubMed ID: 18027158
[TBL] [Abstract][Full Text] [Related]
17. High resolution CT and bronchial reversibility test for diagnosing COPD.
Kurashima K; Takayanagi N; Sato N; Kanauchi T; Hoshi T; Tokunaga D; Ubukata M; Yanagisawa T; Sugita Y; Kanazawa M
Respirology; 2005 Jun; 10(3):316-22. PubMed ID: 15955144
[TBL] [Abstract][Full Text] [Related]
18. Global initiative for chronic obstructive lung disease for chronic obstructive pulmonary disease: GOLD opportunity for lung disorders.
Minas M; Dimitropoulos K; Pastaka Ch; Papadopoulos D; Markoulis N; Gourgoulianis KI
Prev Med; 2005 Mar; 40(3):274-7. PubMed ID: 15533539
[TBL] [Abstract][Full Text] [Related]
19. [Retrospective studies on 713 cases chronic obstructive pulmonary disease].
Li ZP; Huang JQ; Tang KJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Aug; 24(8):722-4. PubMed ID: 14521798
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of COPD in Iceland--the BOLD study].
Benediktsdóttir B; Gudmundsson G; Jörundsdóttir KB; Vollmer W; Gíslason T
Laeknabladid; 2007 Jun; 93(6):471-7. PubMed ID: 17541146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
